Advertisement
Guest User

Untitled

a guest
Nov 18th, 2019
175
0
Never
Not a member of Pastebin yet? Sign Up, it unlocks many cool features!
text 3.28 KB | None | 0 0
  1. => Training Epoch #1, LR=0.0100
  2. | Epoch [ 1/ 20] Loss: 9.1636 Acc@1: 17.816%
  3.  
  4. | Validation Epoch #1 Loss: 7.1251 Acc@1: 25.44%
  5. * Test results : Acc@1 = 30.63%
  6. | Elapsed time : 0:00:46
  7.  
  8. => Training Epoch #2, LR=0.0100
  9. | Epoch [ 2/ 20] Loss: 8.9432 Acc@1: 27.586%
  10.  
  11. | Validation Epoch #2 Loss: 7.4514 Acc@1: 25.68%
  12. * Test results : Acc@1 = 30.63%
  13. | Elapsed time : 0:01:32
  14.  
  15. => Training Epoch #3, LR=0.0100
  16. | Epoch [ 3/ 20] Loss: 7.5626 Acc@1: 31.683%
  17.  
  18. | Validation Epoch #3 Loss: 6.7873 Acc@1: 32.44%
  19. * Test results : Acc@1 = 32.44%
  20. | Elapsed time : 0:02:16
  21.  
  22. => Training Epoch #4, LR=0.0100
  23. | Epoch [ 4/ 20] Loss: 9.2558 Acc@1: 33.957%
  24.  
  25. | Validation Epoch #4 Loss: 9.3281 Acc@1: 29.16%
  26. * Test results : Acc@1 = 32.44%
  27. | Elapsed time : 0:03:01
  28.  
  29. => Training Epoch #5, LR=0.0100
  30. | Epoch [ 5/ 20] Loss: 4.8467 Acc@1: 35.192%
  31.  
  32. | Validation Epoch #5 Loss: 8.7273 Acc@1: 29.60%
  33. * Test results : Acc@1 = 32.44%
  34. | Elapsed time : 0:03:46
  35.  
  36. => Training Epoch #6, LR=0.0100
  37. | Epoch [ 6/ 20] Loss: 5.1729 Acc@1: 36.403%
  38.  
  39. | Validation Epoch #6 Loss: 8.9463 Acc@1: 31.02%
  40. * Test results : Acc@1 = 32.44%
  41. | Elapsed time : 0:04:31
  42.  
  43. => Training Epoch #7, LR=0.0100
  44. | Epoch [ 7/ 20] Loss: 6.6655 Acc@1: 37.784%
  45.  
  46. | Validation Epoch #7 Loss: 7.1685 Acc@1: 31.90%
  47. * Test results : Acc@1 = 32.44%
  48. | Elapsed time : 0:05:16
  49.  
  50. => Training Epoch #8, LR=0.0100
  51. | Epoch [ 8/ 20] Loss: 5.4132 Acc@1: 37.552%
  52.  
  53. | Validation Epoch #8 Loss: 7.6924 Acc@1: 31.12%
  54. * Test results : Acc@1 = 32.44%
  55. | Elapsed time : 0:06:02
  56.  
  57. => Training Epoch #9, LR=0.0100
  58. | Epoch [ 9/ 20] Loss: 6.3544 Acc@1: 38.041%
  59.  
  60. | Validation Epoch #9 Loss: 6.5305 Acc@1: 31.56%
  61. * Test results : Acc@1 = 32.44%
  62. | Elapsed time : 0:06:48
  63.  
  64. => Training Epoch #10, LR=0.0100
  65. | Epoch [ 10/ 20] Loss: 8.4073 Acc@1: 38.322%
  66.  
  67. | Validation Epoch #10 Loss: 7.3700 Acc@1: 33.02%
  68. * Test results : Acc@1 = 33.02%
  69. | Elapsed time : 0:07:33
  70.  
  71. => Training Epoch #11, LR=0.0100
  72. | Epoch [ 11/ 20] Loss: 6.4634 Acc@1: 38.518%
  73.  
  74. | Validation Epoch #11 Loss: 8.0970 Acc@1: 30.87%
  75. * Test results : Acc@1 = 33.02%
  76. | Elapsed time : 0:08:18
  77.  
  78. => Training Epoch #12, LR=0.0100
  79. | Epoch [ 12/ 20] Loss: 7.7321 Acc@1: 39.276%
  80.  
  81. | Validation Epoch #12 Loss: 7.4515 Acc@1: 30.33%
  82. * Test results : Acc@1 = 33.02%
  83. | Elapsed time : 0:09:03
  84.  
  85. => Training Epoch #13, LR=0.0100
  86. | Epoch [ 13/ 20] Loss: 5.9437 Acc@1: 38.946%
  87.  
  88. | Validation Epoch #13 Loss: 8.6938 Acc@1: 32.44%
  89. * Test results : Acc@1 = 33.02%
  90. | Elapsed time : 0:09:48
  91.  
  92. => Training Epoch #14, LR=0.0100
  93. | Epoch [ 14/ 20] Loss: 6.0999 Acc@1: 38.946%
  94.  
  95. | Validation Epoch #14 Loss: 7.2517 Acc@1: 31.02%
  96. * Test results : Acc@1 = 33.02%
  97. | Elapsed time : 0:10:32
  98.  
  99. => Training Epoch #15, LR=0.0100
  100. | Epoch [ 15/ 20] Loss: 7.9859 Acc@1: 39.435%
  101.  
  102. | Validation Epoch #15 Loss: 5.5602 Acc@1: 32.19%
  103. * Test results : Acc@1 = 33.02%
  104. | Elapsed time : 0:11:16
  105.  
  106. => Training Epoch #16, LR=0.0100
  107. | Epoch [ 16/ 20] Loss: 7.9089 Acc@1: 40.046%
  108.  
  109. | Validation Epoch #16 Loss: 9.5848 Acc@1: 31.80%
  110. * Test results : Acc@1 = 33.02%
  111. | Elapsed time : 0:12:02
  112.  
  113. => Training Epoch #17, LR=0.0100
  114. | Epoch [ 17/ 20] Loss: 8.2566 Acc@1: 38.763%
  115.  
  116. | Validation Epoch #17 Loss: 8.0095 Acc@1: 31.36%
  117. * Test results : Acc@1 = 33.02%
  118. | Elapsed time : 0:12:48
Advertisement
Add Comment
Please, Sign In to add comment
Advertisement